11.00–11.05Welcome to HIV Glasgow Day Two

11.05–12.15Biological, Clinical and Ethical Imperatives for Involving Diverse Women
in Clinical Trials
In collaboration with the International AIDS Society (IAS)

11.05–11.10Welcome and introduction
Linda-Gail Bekker, Desmond Tutu HIV Centre, Institute of Infectious Disease and
Molecular Medicine UCT Faculty of Health Sciences, Cape Town, South Africa
Adeeba Kamarulzaman, Faculty of Medicine, University of Malaya, Kuala Lumpar,
Malaysia

11.10–11.20Biological considerations for including women in clinical trials
Catherine Orrell, Desmond Tutu HIV Centre, South Africa

11.20–11.30Importance of including women in trials from a programming point of view
Meg Doherty, Department of Global HIV, Hepatitis and STI Programmes,
World Health Organization, Geneva, Switzerland

11.30–11.40Ethical considerations: why it’s imperative to include women in clinical trials
Maggie Little, PHASES (Pregnancy & HIV/AIDS: Seeking Equitable Study),
Georgetown University Kennedy Institute of Ethics, Washington, DC, USA

11.40–11.55Motivations and experiences as women in clinical trials
Cisgender perspective: Longret Kwardem, Salamander Trust, London, UK
Transgender perspective: Michelle Ross, cliniQ, London, UK

11.55–12.15Panel discussion and Q&A
All

12.15–12.30Break

12.30–13.0090:90:90. Are the Differences Between Women and Men Changing?
In collaboration with the European AIDS Clinical Society (EACS)/Women Against
Viruses in Europe (WAVE)

Chair:Yvonne Gilleece, Brighton & Sussex University Hospitals NHS Trust,
Brighton, UK

12.30–12.4090:90:90. Are the Differences Between Women and Men Changing?
Plenary presentation
Rageshri Dhairyawan, HIV and Sexual Health, Bart’s and the London NHS Trust,
London, UK

12.40–12.5090:90:90. Are the Differences Between Women and Men Changing?
Case presentation
Dagny Krankowska, Department of Infectious and Tropical Diseases and Hepatology, Medical
University of Warsaw, Warsaw, Poland

12.50–13.00Q&A

13.00–13.15Break

13.15–14.30Industry Symposium

14.30–14.45Break

14.45–15.30Tuberculosis Transmission and Clinical Care

14:45-15:00HIV-associated TB: an update on diagnosis and treatment
Graeme Meintjes, Cape Town, South Africa

15:00-15:15Catching Bacilli in Flight: Direct sampling of tuberculosis aerosols
Robin Wood, Cape Town, South Africa

15:15-15:30Q & A

15.30–15.45Break

15.45–17.00HIV Care in the COVID-19 Era: A Community Perspective
In collaboration with the European AIDS Treatment Group (EATG)

Moderator:Brian West, European AIDS Treatment Group, Edinburgh, Scotland

15:45-15:55Overview of services and impact on prevention and care and psychosocial
implications on PLHIV
Ian Hodgson, European AIDS Treatment Group, Bingley, UK

15:55-16:05Rights, emergency measures and beyond
Julian Hows, HIV Justice Network, Amsterdam, The Netherlands

16:05-16:25Community responses to disruption caused by the
COVID-19 crisis
Raminta Stuikyte, Vilnius, Lithuania

16:25-16:33STI and HIV testing to break the chain of infection: local innovation in the midst
of COVID-19
Clare Wood, The Northern Contraception, Sexual Health and HIV Service,
The Hathersage Centre, Manchester, UK

16:33-17:00Discussion and closing remarks
All

17.00–17.15Break

17.15–18.15Challenging Cases in HIV
In collaboration with the International Antiviral Society-USA (IAS-USA)